SA53 Understanding the Real-World Evidence Published on FDA-Approved Immunotherapies in Oncology in the United States — a Targeted Literature Review

Abstract

As immunotherapies are becoming standard for several cancers, an increasing amount of real-world evidence (RWE) is being generated to understand the wholistic view of these therapies. The aim of this targeted literature review was to understand and summarize key characteristics of the RWE published on FDA-approved immunotherapies across 17 different cancers. Methodology: Cochrane’s Rapid Review methodology was followed with an exhaustive search using PubMed, EMBASE, and Cochrane databases 2011 onwards (approval of first immunotherapy) for United States (US).